Dr. Sang Ahn, M.D

NPI: 1568581759
Total Payments
$9,650
2024 Payments
$48.36
Companies
37
Transactions
290
Medicare Patients
4,259
Medicare Billing
$732,335

Payment Breakdown by Category

Food & Beverage$4,818 (49.9%)
Other$2,500 (25.9%)
Consulting$1,995 (20.7%)
Education$336.75 (3.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,818 265 49.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,500 2 25.9%
Consulting Fee $1,995 1 20.7%
Education $336.75 22 3.5%

Top Paying Companies

Company Total Records Latest Year
Eisai Inc. $4,495 3 $0 (2021)
PFIZER INC. $618.88 43 $0 (2023)
Amgen Inc. $493.93 20 $0 (2018)
E.R. Squibb & Sons, L.L.C. $463.93 32 $0 (2018)
Genentech USA, Inc. $317.30 19 $0 (2018)
Millennium Pharmaceuticals, Inc. $303.96 9 $0 (2017)
AstraZeneca Pharmaceuticals LP $246.04 14 $0 (2018)
INSYS Therapeutics Inc $213.64 11 $0 (2018)
Incyte Corporation $189.64 10 $0 (2017)
Merck Sharp & Dohme LLC $184.82 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $48.36 3 Merck Sharp & Dohme LLC ($18.09)
2023 $102.27 6 PFIZER INC. ($46.74)
2022 $133.36 6 PFIZER INC. ($63.98)
2021 $2,620 11 Eisai Inc. ($2,500)
2020 $1,995 1 Eisai Inc. ($1,995)
2019 $73.05 4 Allergan Inc. ($52.67)
2018 $608.77 28 Takeda Pharmaceuticals U.S.A., Inc. ($119.08)
2017 $4,069 231 E.R. Squibb & Sons, L.L.C. ($446.39)

All Payment Transactions

290 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/23/2024 Merck Sharp & Dohme LLC WELIREG (Drug) Education In-kind items and services $18.09 General
Category: ONCOLOGY
05/29/2024 Agios Pharmaceuticals, Inc. PYRUKYND (Drug) Education In-kind items and services $16.53 General
Category: Genetically Defined Disease
02/14/2024 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $13.74 General
Category: Oncology
10/03/2023 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $20.91 General
Category: Oncology
04/21/2023 Boston Scientific Corporation WaveWriter Alpha Prime 16 (Device) Food and Beverage In-kind items and services $19.62 General
Category: WaveWriter Alpha_NMD
03/02/2023 PFIZER INC. LORBRENA (Drug) Education In-kind items and services $15.50 General
Category: ONCOLOGY
02/07/2023 Boston Scientific Corporation LUX-Dx Insertable Cardiac Monitor (Device) Food and Beverage In-kind items and services $15.00 General
Category: LUX-Dx_CRM
02/04/2023 PFIZER INC. IBRANCE (Drug), PAXLOVID Food and Beverage In-kind items and services $17.90 General
Category: ONCOLOGY
01/06/2023 PFIZER INC. INLYTA (Drug) Education In-kind items and services $13.34 General
Category: ONCOLOGY
11/08/2022 Takeda Pharmaceuticals U.S.A., Inc. ICLUSIG (Drug) Education In-kind items and services $32.75 General
Category: ONCOLOGY
09/30/2022 PFIZER INC. IBRANCE (Drug) Food and Beverage In-kind items and services $25.12 General
Category: ONCOLOGY
08/11/2022 Myriad Genetic Laboratories, Inc. myRisk (Device) Food and Beverage Cash or cash equivalent $17.50 General
Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis
03/31/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $19.13 General
Category: RESPIRATORY
01/14/2022 PFIZER INC. INLYTA (Drug) Education In-kind items and services $13.34 General
Category: ONCOLOGY
01/07/2022 PFIZER INC. INLYTA (Drug) Education In-kind items and services $25.52 General
Category: ONCOLOGY
12/09/2021 PFIZER INC. INLYTA (Drug), BAVENCIO, LORBRENA Food and Beverage In-kind items and services $23.34 General
Category: ONCOLOGY
11/18/2021 PFIZER INC. INLYTA (Drug) Education In-kind items and services $25.52 General
Category: ONCOLOGY
10/22/2021 Eisai Inc. Lenvima (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: Oncology
10/21/2021 PFIZER INC. INLYTA (Drug) Education In-kind items and services $7.60 General
Category: ONCOLOGY
08/11/2021 Eisai Inc. Lenvima (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: Oncology
07/21/2021 PFIZER INC. INLYTA (Drug) Food and Beverage In-kind items and services $22.82 General
Category: ONCOLOGY
07/19/2021 PFIZER INC. INLYTA (Drug) Education In-kind items and services $8.16 General
Category: ONCOLOGY
07/12/2021 PFIZER INC. INLYTA (Drug) Education In-kind items and services $8.20 General
Category: ONCOLOGY
07/09/2021 PFIZER INC. INLYTA (Drug) Education In-kind items and services $8.16 General
Category: ONCOLOGY
04/21/2021 PFIZER INC. INLYTA (Drug) Education In-kind items and services $8.16 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 869 1,397 $518,360 $92,679
2022 9 1,123 2,279 $970,360 $187,407
2021 9 1,117 2,561 $1.2M $241,754
2020 11 1,150 2,780 $1.1M $210,496
Total Patients
4,259
Total Services
9,017
Medicare Billing
$732,335
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 337 659 $263,600 $46,346 17.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 98 151 $80,785 $17,096 21.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 68 68 $51,000 $9,802 19.2%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2023 205 326 $55,420 $8,644 15.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 62 62 $37,200 $6,196 16.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 42 47 $12,925 $1,941 15.0%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 27 30 $8,250 $1,344 16.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 30 54 $9,180 $1,310 14.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 425 1,225 $490,000 $91,987 18.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 217 492 $263,220 $56,913 21.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 88 88 $66,000 $12,281 18.6%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 123 155 $62,000 $9,836 15.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 95 109 $29,975 $5,671 18.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 47 47 $28,200 $5,147 18.3%
99441 Telephone medical discussion with physician, 5-10 minutes Office 2022 66 78 $13,260 $2,314 17.5%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 35 54 $9,180 $1,637 17.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 27 31 $8,525 $1,620 19.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 294 882 $471,870 $107,914 22.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 353 954 $381,600 $71,929 18.8%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 206 357 $142,800 $28,239 19.8%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 117 117 $87,750 $16,357 18.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 38 98 $16,660 $6,065 36.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 18 52 $13,000 $4,462 34.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 41 41 $24,600 $3,256 13.2%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 36 44 $12,100 $2,147 17.7%

About Dr. Sang Ahn, M.D

Dr. Sang Ahn, M.D is a Specialist healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568581759.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sang Ahn, M.D has received a total of $9,650 in payments from pharmaceutical and medical device companies, with $48.36 received in 2024. These payments were reported across 290 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,818).

As a Medicare-enrolled provider, Ahn has provided services to 4,259 Medicare beneficiaries, totaling 9,017 services with total Medicare billing of $732,335. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Hematology & Oncology
  • Location Los Angeles, CA
  • Active Since 03/28/2007
  • Last Updated 11/27/2023
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1568581759

Products in Payments

  • Lenvima (Drug) $4,495
  • OPDIVO (Biological) $411.41
  • NINLARO (Drug) $402.48
  • XTANDI (Drug) $210.95
  • Nplate (Biological) $194.51
  • INLYTA (Drug) $191.71
  • JAKAFI (Drug) $189.64
  • Cabometyx (Drug) $184.80
  • GILOTRIF (Drug) $181.94
  • Kyprolis (Biological) $168.55
  • KEYTRUDA (Biological) $166.73
  • Avastin (Biological) $158.40
  • Imbruvica (Drug) $155.15
  • SYNDROS (Drug) $148.28
  • TAGRISSO (Drug) $127.23
  • TECENTRIQ (Biological) $114.39
  • Xtandi (Drug) $100.78
  • Rubraca (Drug) $100.60
  • FASLODEX (Drug) $95.99
  • IBRANCE (Drug) $93.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Los Angeles